OBJECTIVES: Opium use, particularly in low doses, is a common practice among adults in northeastern Iran. We aimed to investigate the association between opium use and subsequent mortality from disorders of the digestive tract. METHODS: We used data from the Golestan Cohort Study, a prospective cohort study in northeastern Iran, with detailed, validated data on opium use and several other exposures. A total of 50,045 adults were enrolled during a 4-year period (2004-2008) and followed annually until December 2012, with a follow-up success rate of 99%. We used Cox proportional hazard regression models to evaluate the association between opium use and outcomes of interest. RESULTS: In all, 8,487 (17%) participants reported opium use, with a mean duration of 12.7 years. During the follow-up period 474 deaths from digestive diseases were reported (387 due to gastrointestinal cancers and 87 due to nonmalignant etiologies). Opium use was associated with an increased risk of death from any digestive disease (adjusted hazard ratio (HR)=1.55, 95% confidence interval (CI)=1.24-1.93). The association was dose dependent, with a HR of 2.21 (1.57-3.31) for the highest quintile of cumulative opium use vs. no use (Ptrend=0.037). The HRs (95% CI) for the associations between opium use and malignant and nonmalignant causes of digestive mortality were 1.38 (1.07-1.76) and 2.60 (1.57-4.31), respectively. Increased risks were seen both for smoking opium and for ingestion of opium. CONCLUSIONS: Long-term opium use, even in low doses, is associated with increased risk of death from both malignant and nonmalignant digestive diseases.
OBJECTIVES: Opium use, particularly in low doses, is a common practice among adults in northeastern Iran. We aimed to investigate the association between opium use and subsequent mortality from disorders of the digestive tract. METHODS: We used data from the Golestan Cohort Study, a prospective cohort study in northeastern Iran, with detailed, validated data on opium use and several other exposures. A total of 50,045 adults were enrolled during a 4-year period (2004-2008) and followed annually until December 2012, with a follow-up success rate of 99%. We used Cox proportional hazard regression models to evaluate the association between opium use and outcomes of interest. RESULTS: In all, 8,487 (17%) participants reported opium use, with a mean duration of 12.7 years. During the follow-up period 474 deaths from digestive diseases were reported (387 due to gastrointestinal cancers and 87 due to nonmalignant etiologies). Opium use was associated with an increased risk of death from any digestive disease (adjusted hazard ratio (HR)=1.55, 95% confidence interval (CI)=1.24-1.93). The association was dose dependent, with a HR of 2.21 (1.57-3.31) for the highest quintile of cumulative opium use vs. no use (Ptrend=0.037). The HRs (95% CI) for the associations between opium use and malignant and nonmalignant causes of digestive mortality were 1.38 (1.07-1.76) and 2.60 (1.57-4.31), respectively. Increased risks were seen both for smoking opium and for ingestion of opium. CONCLUSIONS: Long-term opium use, even in low doses, is associated with increased risk of death from both malignant and nonmalignant digestive diseases.
Authors: Abdullah Gandomkar; Hossein Poustchi; Maryam Moini; Mohsen Moghadami; Hadi Imanieh; Mohammad Reza Fattahi; Seyyed Mohammad Taghi Ayatollahi; Mohammad Mahdi Sagheb; Amir Anushiravani; Roozbeh Mortazavi; Sadaf Ghajarieh Sepanlou; Reza Malekzadeh Journal: Int J Public Health Date: 2016-06-28 Impact factor: 3.380
Authors: Arash Etemadi; Hossein Poustchi; Antonia M Calafat; Benjamin C Blount; Victor R De Jesús; Lanqing Wang; Akram Pourshams; Ramin Shakeri; Maki Inoue-Choi; Meredith S Shiels; Gholamreza Roshandel; Gwen Murphy; Connie S Sosnoff; Deepak Bhandari; Jun Feng; Baoyun Xia; Yuesong Wang; Lei Meng; Farin Kamangar; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Neal D Freedman Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-01-08 Impact factor: 4.254
Authors: Akbar Fazel-Tabar Malekshah; Marsa Zaroudi; Arash Etemadi; Farhad Islami; Sadaf Sepanlou; Maryam Sharafkhah; Abbas-Ali Keshtkar; Hooman Khademi; Hossein Poustchi; Azita Hekmatdoost; Akram Pourshams; Akbar Feiz Sani; Elham Jafari; Farin Kamangar; Sanford M Dawsey; Christian C Abnet; Paul D Pharoah; Paul J Berennan; Paolo Boffetta; Ahmad Esmaillzadeh; Reza Malekzadeh Journal: Arch Iran Med Date: 2016-11 Impact factor: 1.354
Authors: Atieh Rahmati; Ramin Shakeri; Hooman Khademi; Hossein Poutschi; Akram Pourshams; Arash Etemadi; Masoud Khoshnia; Amir Ali Sohrabpour; Ali Aliasgari; Elham Jafari; Farhad Islami; Shahryar Semnani; Abdolsamad Gharravi; Christian C Abnet; Paul D P Pharoah; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh; Farin Kamangar Journal: Thorax Date: 2016-11-24 Impact factor: 9.139